Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Flow-mediated dilation (FMD) (%) placebo versus simvastatin (familial hypercholesterolemia [FH]) at baseline and 28 weeks. Striped bar = baseline; white bar = 28 weeks. *p < 0.0001 vs. baseline;  p < 0.05,  FMD placebo vs. FMD simvastatin.
|
